The Current Ratio as of November 2024 (TTM) for ProKidney Corp. (PROK) is 21.87

According to ProKidney Corp.’s latest financial reports and current stock price. The company's current Current Ratio is 21.87. This represents a change of 18.53% compared to the average of 18.45 of the last 4 quarters.

ProKidney Corp. (PROK) Historical Current Ratio (quarterly & annually)

How has PROK Current Ratio performed in the past?

The mean historical Current Ratio of ProKidney Corp. over the last ten years is 14.06. The current 21.87 Current Ratio has changed 15.46% with respect to the historical average. Over the past ten years (40 quarters), PROK's Current Ratio was at its highest in in the September 2022 quarter at 52.78. The Current Ratio was at its lowest in in the September 2001 quarter at 0.

ProKidney Corp. (PROK) Current Ratio by Quarter and Year

Discovering the peaks and valleys of ProKidney Corp. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

ProKidney Corp. (PROK) Average Current Ratio

How has PROK Current Ratio performed in the past?

The current Current Ratio of ProKidney Corp. (PROK) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

ProKidney Corp. (PROK) Current Ratio vs. Peers

How is PROK’s Current Ratio compared to its peers?

ProKidney Corp.’s Current Ratio is greater than Relay Therapeutics, Inc. (15.64), greater than Stoke Therapeutics, Inc. (6.67), greater than Pliant Therapeutics, Inc. (14.47), greater than Black Diamond Therapeutics, Inc. (6.87), greater than Arvinas, Inc. (4.17), greater than Arcellx, Inc. (6.01), greater than Ventyx Biosciences, Inc. (14.19), greater than Immunocore Holdings plc (5.17), greater than Vaxcyte, Inc. (17.88), less than DICE Therapeutics, Inc. (25.88), less than Third Harmonic Bio, Inc. (41.13), greater than PMV Pharmaceuticals, Inc. (19.22), less than Edgewise Therapeutics, Inc. (30.24), greater than Enochian Biosciences, Inc. (0.07), greater than Revolution Medicines, Inc. (15.42), greater than Kura Oncology, Inc. (14.94), greater than Protagonist Therapeutics, Inc. (13.73), greater than Merus N.V. (8.32), greater than Replimune Group, Inc. (13.46), greater than Cerevel Therapeutics Holdings, Inc. (10.22), greater than Monte Rosa Therapeutics, Inc. (6.56), greater than Erasca, Inc. (16.79), greater than Lyell Immunopharma, Inc. (16.19),

Build a custom stock screener for ProKidney Corp. (PROK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ProKidney Corp. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ProKidney Corp. (PROK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ProKidney Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.